Respiratory Pharm Flashcards
describe asthma
- Chronic inflammation of the airways
- Bronchial hyperresponsiveness
- Airflow obstruction
- reversible
inflammation in airway secretion from asthma results in
- Bronchiolar Smooth Muscle Spasm
- Airway Hyperresponsiveness
- Airway Edema
- Increased Mucus Secretion
classify asthma based on severity

overview of drugs for asthma management

list the inhaled short-acting β2 adrenergic agonists (SABAs)
Albuterol
Terbutaline
Pirbuterol
list the Inhaled long-acting β2 adrenergic agonists (LABAs)
Salmeterol
Formoterol
describe the MOA of β2 Adrenergic Agonists
- Binds/activates β2 adrenergic receptors on airway smooth muscle cells
- Activation of β2 receptors stimulates adenylyl cyclase and increases formation of cAMP
- cAMP activates protein kinase A which phosphorylates and inactivates myosin light chain kinase → relaxation of the airway smooth muscle cells and bronchodilation
___ are the DOC for relief of acute asthma symptoms and prevention of exercise-induced bronchospasm
SABAs are the DOC for relief of acute asthma symptoms and prevention of exercise-induced bronchospasm
LABAs are combined with ____ for long-term control in moderate and severe persistent asthma
LABAs shouldn’t be used as ___ for long-term control of asthma as they have no _____
Are LABAs used for treating acute asthma symptoms?
LABAs are combined with inhaled corticosteroids (ICS) for long-term control in moderate and severe persistent asthma
LABAs shouldn’t be used as monotherapy for long-term control of asthma as they have no anti-inflammatory action
LABAs are NOT used for acute astham symptoms
list AEs of β2 Adrenergic Agonists
-
tachycardia, tremor, and hypokalemia
- reduced via inhalation administration
- LABAs increase risk of serious asthma- related events (hospitalization, intubation, and death)
list the Inhaled Short-Acting Muscarinic Antagonists (SAMAs)
Ipratropium
list the Inhaled Long-Acting Muscarinic Antagonists (LAMAs)
Tiotropium
what is the MOA of ipratropium and tiotropium
block muscarinic receptors on the airways causing bronchodilation and reduction of respiratory secretions
Ipratropium is less effective than ____
but provides additive benefit to SABAs in the management of moderate to severe exacerbations of asthma
Ipratropium is less effective than SABAs
but provides additive benefit to SABAs in the management of moderate to severe exacerbations of asthma
____ is the DOC for β-blocker-induced bronchospasm
Ipratropium is the DOC for β-blocker-induced bronchospasm
____ may be added to ICS for long-term control of severe persistent asthma
Tiotropium may be added to ICS for long-term control of severe persistent asthma
list the Anticholinergic AEs
- quaternary ammonium compounds
- minor anticholinergic effects, e.g. xerostomia
- may be safer than SABAs in patients with cardiovascular disease
Methylxanthines
Theophylline
Theophylline inhibits ____, increasing ____ evoking bronchodilation
Theophylline inhibits phosphodiesterase, increasing cAMP evoking bronchodilation
____ can be given orally or IV and is ___ therapy for patients with persistent asthma
Theophylline can be given orally or IV and is alternate therapy for patients with persistent asthma
list the AEs of Theophylline
- Largely replaced by β2 agonists and corticosteroids due to narrow therapeutic window, adverse effects, and potential for drug interactions
- most common: headache, nausea, vomiting, abdominal discomfort, and restlessness
- At high concentrations: cardiac arrhythmias and seizures
list the inhaled corticosteroids (ICS)
Beclomethasone
Fluticasone
Flunisolide
Budesonide
list the systemic corticosteroids
Prednisolone
Dexamethasone
Glucocorticoids inhibit ____ and ____, resulting in reduced formation of leukotrienes and prostaglandins
Glucocorticoids inhibit phospholipase A2 and COX-2, resulting in reduced formation of leukotrienes and prostaglandins
Prolonged use of SABAs results in β2 receptors desensitization…
____ prevent or reverse this desensitization
Prolonged use of SABAs results in β2 receptors desensitization…
corticosteroids prevent or reverse this desensitization
____ are the most effective long-term control medication in the management of persistent asthma.
corticosteroids are the most effective long-term control medication in the management of persistent asthma.
Oral ____may be added to ICS for long-term control of severe persistent asthma
Oral prednisolone may be added to ICS for long-term control of severe persistent asthma
A short course of _____ is used for moderate and severe acute exacerbations of asthma to speed recovery and to prevent recurrence of exacerbations
A short course of systemic corticosteroids is used for moderate and severe acute exacerbations of asthma to speed recovery and to prevent recurrence of exacerbations
list the AEs of inhaled ICS
- Inhaled CS = lower bioavailability than systemic CS → less adverse effects
- Local AEs:
- oropharyngeal candidiasis
- dysphonia, reflex cough and bronchospasm
- Long-term use:
- osteoporosis and cataracts
- may cause deceleration of vertical growth in children
Long term use of systemic glucocorticoids may result in ____ and _____
Long term use of systemic glucocorticoids may result in hypercortisolism and Cushing’s syndrome
list the anti-inflammatory drugs: Release Inhibitors
Cromolyn
Nedocromil
Cromolyn and Nedocromil act by inhibiting _____, and prevent both antigen- and exercise-induced bronchospasm in asthmatic patients
Are they useful in managing acute asthma attack?
Cromolyn and Nedocromil act by inhibiting mast cell degranulation, and prevent both antigen- and exercise-induced bronchospasm in asthmatic patients
NO- not useful for acute asthma attack! because they are not bronchodilators
list AEs for release inhibitors: Cromolyn and Nedocromil
- Throat irritation, cough, mouth dryness.
- Rarely, chest tightness and wheezing
- reversible dermatitis, myositis, or gastroenteritis, pulmonary infiltration with eosinophilia and anaphylaxis.
____ is a monoclonal antibody and prevents binding of ____ to basophils and mast cells.
It is used for patients with ____ persistent asthma with evidence of allergy
Omalizumab is a monoclonal antibody and prevents binding of IgE to basophils and mast cells.
It is used for patients with severe persistent asthma with evidence of allergy
Omalizumab AE?
Anaphylaxis
list the:
- Leukotriene Receptor Antagonists (LTRAs)
- 5-Lipoxygenase inhibitors
- LTRA: Montelukast, Zafirlukast
- 5-LOX inhibitor: Zileuton
- all taken orally

what is the use for leukotriene-modifying agents?
- Alternative therapy
- prevention of exercise-induced bronchospasm
- management of NSAID-exacerbated respiratory disease (NERD)
list the AEs for leukotrine-modifying agents
-
Montelukast:
- insomnia, anxiety, depression, suicidal thinking
-
Zileuton:
- Hepatotoxicity
describe ways to manage acute exacerbations of asthma
- Inhaled SABAs
- Inhaled SAMAs
- Systemic corticosteroids
describe long term management of asthma

describe COPD
- chronic, progressive
- irreversible obstruction of the airflow
- most important risk factor: Smoking
- 3 cardinal symptoms of COPD:
- dyspnea
- chronic cough
- sputum production
overview of drugs to manage COPD

drugs used for symptomatic relief and in management of acute exacerbations of COPD?
- short acting bronchodilators:
- SABAs
- SAMAs
- systemic cortisoids
- Oral prednisolone
drugs used for long-term control of COPD
- long acting bronchodilators
- LABAs
- LAMAs
- Inhaled corticosteroids:
- Fluticasone and budesonide
the mucolytic agent used in COPD ____ → breaks ___ linkages in mucus and lowers viscosity.
the mucolytic agent used in COPD N-Acetylcysteine → breaks disulfide linkages in mucus and lowers viscosity
drugs for treating allergic rhinitis
- Glucocorticoid nasal sprays (1st line)
- Oral antihistamines
- Cromolyn sodium
- Montelukast
- Nasal Decongestants- α adrenergic agonists
- Phenylephrine
- Pseudoephedrine
list AEs of Glucocorticoids
- local irritation of the nasal mucosa
- nosebleed
- nasal septal perforation
- nasopharyngeal candidiasis
oral antihistamines

describe the drugs used for coughing
Codeine and dextromethorphan
- Suppress cough reflex via a direct action on the cough center in the medulla of the brain
- Adverse effects: constipation and drowsiness
- Dextromethorphan = safer, lower abuse potential than codeine